Drugs / T-DXd
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07134153 | Apr 2025 → Aug 2026 overdue | breast cancer | Fudan University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | T-DXd | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07134153 ↗ |
| Route | Intrathecal | “intrathecal or ommaya reservoir administration of T-DXd” NCT07134153 ↗ |